Summary
OFTALMED has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,000. Equity remains stable across the filed financial years (±1.3% per year). Its solvency ranks better than 10% of 3,009 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€305,055total assets 2025
- Staff
- 4.6 FTE
- Equity
- €15,000
Turnover not published (abbreviated format)
Financial health
- Bankruptcy probabilitywithin 12 months
- 0.1%
Too few figures to score
Structure
2025 accounts 105 days early2 deeds in the Belgian Official Gazette
Signalsraises riskEquity €15,000 (4.9% of total assets)Weak solvency vs sectorlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.85, cash €118,234Figures for financial year 2025 (filed 20-04-2026)neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%lowest value
12-2024: 0.1%● unchanged vs 11-2024lowest value
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026highest value
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 3009 sector peers (2025).
NBB · sector comparisonPosition among 3009 sector peers
Solvency
better than 10%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-04-2026, 105 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
105 days early
2024
6 days early
2023
7 days early
2022
4 days early
2021
29 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 19 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 filed years within 35 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · abbreviated…
- Annual accounts filedfinancial year 2023 · abbreviated…
Financials · financial year 2025, abbreviated format
Equity
€15,000=
2024 · €15,000
Total assets
€305,055▲ 23.9%
2024 · €246,309
Net result
€262▼ 97.5%
2022 · €10,505
Working capital
€68,094▲ 186%
2024 · €23,841
Trend over the years
2021 to 2025, 5 financial years
The operating result recovers in 2025; 2025 is 52% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€5,973
2025
Net result€262
2023
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€305,055
2025
Equity€15,000
2025
Debt€290,055
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€68,094
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)0.1%
2023
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency4.9%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio1.85
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)4.6
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line20212022202320242025
Operating result-€802-€13,680€4,239▼ 69.0%€3,920▼ 7.5%€5,973▲ 52.4%
Net result-€10,767below the sector's middle half-€10,505below the sector's middle half€262below the sector's middle half▼ 97.5%
Equity€4,233below the sector's middle half-€14,738below the sector's middle half▲ 248%€15,000below the sector's middle half▲ 1.8%€15,000below the sector's middle half=€15,000below the sector's middle half=
Total assets€446,861below the sector's middle half-€306,994below the sector's middle half▼ 31.3%€287,129below the sector's middle half▼ 6.5%€246,309below the sector's middle half▼ 14.2%€305,055below the sector's middle half▲ 23.9%
Debt€442,628-€292,255▼ 34.0%€272,129▼ 6.9%€231,309▼ 15.0%€290,055▲ 25.4%
Working capital-€75,407below the sector's middle half-€6,513below the sector's middle half€26,106below the sector's middle half▲ 301%€23,841below the sector's middle half▼ 8.7%€68,094within the sector's middle half▲ 186%
Solvency0.9%below the sector's middle half-4.8%below the sector's middle half▲ 3.9pp5.2%below the sector's middle half▲ 0.4pp6.1%below the sector's middle half▲ 0.9pp4.9%below the sector's middle half▼ 1.2pp
Current ratio0.74below the sector's middle half-1.09below the sector's middle half▲ 0.351.36within the sector's middle half▲ 0.271.28within the sector's middle half▼ 0.071.85within the sector's middle half▲ 0.57
Return on assets (ROA)-2.4%below the sector's middle half-3.4%below the sector's middle half▲ 5.8pp0.1%below the sector's middle half▼ 3.3pp
Staff (FTE)3.1within the sector's middle half-3.4within the sector's middle half▲ 9.7%3.3within the sector's middle half▼ 2.9%3.8within the sector's middle half▲ 15.2%4.6within the sector's middle half▲ 21.1%
above
within
below
the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €305,055
Fixed assets
€156,866 ▲ 13.3%
Current assets
€148,190 ▲ 37.4%
Equity and liabilities €305,055
Equity
€15,000 =
Debt
€290,055 ▲ 25.4%
Debt's share of the balance-sheet total rises from 93.9% to 95.1%. Debt is higher.
Key figures and ratios
EBITDA
€58,132▲
2024 · €56,838
Debt to equity
19.34▲
2024 · 15.42
Interest coverage
9.52▼
2024 · 14.50
Debt ≤ 1 year
€80,095▼
2024 · €83,976
Debt > 1 year
€87,073▲
2024 · €66,189
Staff costs
€240,666▲
2024 · €197,921
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €155,054 | €171,375 | €190,137 | €197,921 | €240,666 | ▲ 21.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €55,107 | €53,283 | €58,026 | €52,918 | €52,159 | ▼ 1.4% |
| Other operating charges640/8 | €871 | €4,981 | €5,972 | €6,189 | €8,628 | ▲ 39.4% |
| Gross operating margin9900 | €210,230 | €243,319 | €258,374 | €260,948 | €307,426 | ▲ 17.8% |
| Operating profit (loss)9901 | -€802 | €13,680 | €4,239 | €3,920 | €5,973 | ▲ 52.4% |
| Financial income75/76B | - | - | - | - | €133 | - |
| Recurring financial income75 | - | - | - | - | €133 | - |
| Financial charges65/66B | €9,965 | €3,175 | €3,977 | €3,920 | €6,106 | ▲ 55.8% |
| Recurring financial charges65 | €9,965 | €3,175 | €3,977 | €3,920 | €6,106 | ▲ 55.8% |
| Profit (loss) for the period before taxes9903 | -€10,767 | €10,505 | €262 | - | - | - |
| Profit (loss) for the period9904 | -€10,767 | €10,505 | €262 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | -€10,767 | €10,505 | €262 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €446,861 | €306,994 | €287,129 | €246,309 | €305,055 | ▲ 23.9% |
| Fixed assets21/28 | €237,062 | €226,279 | €187,600 | €138,492 | €156,866 | ▲ 13.3% |
| Tangible fixed assets22/27 | €237,062 | €226,279 | €187,600 | €138,492 | €156,866 | ▲ 13.3% |
| Plant, machinery and equipment23 | €99,572 | €70,844 | €59,120 | €35,619 | €16,171 | ▼ 54.6% |
| Furniture and vehicles24 | €1,812 | €1,386 | €960 | €1,882 | €1,185 | ▼ 37.0% |
| Leasing and similar rights25 | €135,678 | €154,049 | €127,520 | €100,991 | €139,510 | ▲ 38.1% |
| Current assets29/58 | €209,799 | €80,715 | €99,529 | €107,817 | €148,190 | ▲ 37.4% |
| Amounts receivable within one year40/41 | €25,722 | €9,197 | €11,631 | €15,172 | €10,599 | ▼ 30.1% |
| Trade receivables40 | €25,722 | €2,404 | €8,602 | €10,070 | €7,035 | ▼ 30.1% |
| Other amounts receivable41 | - | €6,793 | €3,029 | €5,102 | €3,564 | ▼ 30.1% |
| Cash at bank and in hand54/58 | €184,078 | €70,573 | €76,216 | €69,310 | €118,234 | ▲ 70.6% |
| Deferred charges and accrued income490/1 | - | €944 | €11,682 | €23,335 | €19,356 | ▼ 17.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €446,861 | €306,994 | €287,129 | €246,309 | €305,055 | ▲ 23.9% |
| Equity10/15 | €4,233 | €14,738 | €15,000 | €15,000 | €15,000 | = |
| Contributions10/11 | €15,000 | €15,000 | €15,000 | €15,000 | €15,000 | = |
| Profit (loss) carried forward14 | -€10,767 | -€262 | - | - | - | - |
| Amounts payable17/49 | €442,628 | €292,255 | €272,129 | €231,309 | €290,055 | ▲ 25.4% |
| Amounts payable after more than one year17 | €157,421 | €153,210 | €109,087 | €66,189 | €87,073 | ▲ 31.6% |
| Financial debts170/4 | €157,421 | €153,210 | €109,087 | €66,189 | €87,073 | ▲ 31.6% |
| Amounts payable within one year42/48 | €285,206 | €74,202 | €73,424 | €83,976 | €80,095 | ▼ 4.6% |
| Current portion of amounts payable after more than one year42 | €37,808 | €43,833 | €44,123 | €42,899 | €39,629 | ▼ 7.6% |
| Trade debts44 | €239,568 | €5,761 | €14,181 | €22,518 | €23,134 | ▲ 2.7% |
| Suppliers440/4 | €239,568 | €5,761 | €14,181 | €22,518 | €23,134 | ▲ 2.7% |
| Taxes, remuneration and social security45 | €7,519 | €11,929 | €13,858 | €16,047 | €15,804 | ▼ 1.5% |
| Taxes450/3 | - | €1,476 | €2,555 | €1,921 | €1,998 | ▲ 4.0% |
| Remuneration and social security454/9 | €7,519 | €10,453 | €11,302 | €14,125 | €13,807 | ▼ 2.3% |
| Other amounts payable47/48 | €312 | €12,679 | €1,262 | €2,512 | €1,528 | ▼ 39.2% |
| Accrued charges and deferred income492/3 | - | €64,843 | €89,618 | €81,145 | €122,887 | ▲ 51.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€10,767 | €10,505 | €262 | - | - | - |
| + Depreciation and write-downs630 | €55,107 | €53,283 | €58,026 | €52,918 | €52,159 | ▼ 1.4% |
| Operating cash flow (approximation) | €44,340 | €63,788 | €58,287 | €52,918 | €52,159 | ▼ 1.4% |
| Investment in fixed assets (approximation) | - | -€42,500 | -€19,347 | -€3,811 | -€70,533 | ▼ 1,751% |
| Change in cash | - | -€113,504 | €5,642 | -€6,906 | €48,924 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (5)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 17-04-2026 | 2026-00082736 |
| 31-12-2024 | abbreviated format | 25-07-2025 | 2025-00306331 |
| 31-12-2023 | abbreviated format | 24-07-2024 | 2024-00286576 |
| 31-12-2022 | abbreviated format | 27-07-2023 | 2023-00282361 |
| 31-12-2021 | abbreviated format | 29-08-2022 | 2022-20344580 |
Similar companies · same sector, comparable size
Dr. Wout De Ruyck Psychiatrie
BE 0735.437.865
Nazareth-De Pinte · equity €15,000
Dr. ANNE CLAES
BE 0764.722.660
Eupen · equity €15,000
ZMACK
BE 0787.866.959
Antwerpen · equity €15,000
Doktersassociatie Schol & Vanhandenhove
BE 0668.958.421
Antwerpen · equity €14,976
CENTRE ESTHÉTIQUE LASER
BE 0662.835.840
Liège · equity €14,961
Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,115. 2,868 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Subsidies and aid
Flemish government
2025 · 1 entry · €1,220 awarded · €1,220 paidPublic contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
17-04
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
25-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
24-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
27-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Back to profitnet €10,505
Net result €10,505 after one loss-making year.
29-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPrivate limited company
Founded24-09-2020
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0754865282
Also
9925:BE0754865282
Registered
20-06-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 27 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Sint-Truiden · 1 establishment unit since 2020
Ground area
832 m²
Building footprint
442 m²
Building volume
4,834 m³
Parcel 71053H1008/00D000, Flanders · tallest building 16.7 m. Linked by address, not a title deed.
10
companies at this address
See who is registered here
1 establishment unit
OFTALMED
since 2020unit no. 2.307.536.859
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 71053H1008/00D000 | Flanders | 832 m² | 1 · 442 m² | 16.7 m · 3 |
How the parcels are linked
Good to know
The parcel matches the address exactly.
1 of these parcels carries protected heritage: expect extra rules on renovation or sale.